MIRA Pharmaceuticals
MIRA
26 hedge funds and large institutions have $2.3M invested in MIRA Pharmaceuticals in 2026 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 6 increasing their positions, 1 reducing their positions, and 5 closing their positions.
500% more repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 1
40% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 5
4% more funds holding
Funds holding: 25 → 26 (+1)
0.17% less ownership
Funds ownership: 5.29% → 5.13% (-0.17%)
31% less capital invested
Capital invested by funds: $3.35M → $2.3M (-$1.05M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$31.5K |
| 2 |
FMI
Frec Markets Inc
San Francisco,
California
|
+$27.6K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
+$22.6K |
| 4 |
XT
XTX Topco
George Town,
Cayman Islands
|
+$20.9K |
| 5 |
Commonwealth Equity Services
Waltham,
Massachusetts
|
+$6.12K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Mirae Asset Global ETFs Holdings
Causeway Bay,
Hong Kong
|
-$472K |
| 2 |
Two Sigma Investments
New York
|
-$40.8K |
| 3 |
Creative Planning
Overland Park,
Kansas
|
-$34.1K |
| 4 |
AQR Capital Management
Greenwich,
Connecticut
|
-$33.2K |
| 5 |
SEM
Suncoast Equity Management
Tampa,
Florida
|
-$15.9K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
CIAM
26
Caitong International Asset Management
Hong Kong
| $1 | +$1 | +1 | New |
|
|
27
Mirae Asset Global ETFs Holdings
Causeway Bay,
Hong Kong
| – | -$472K | -312,777 | Closed |
|
|
28
Two Sigma Investments
New York
| – | -$40.8K | -27,044 | Closed |
|
|
29
Creative Planning
Overland Park,
Kansas
| – | -$34.1K | -22,599 | Closed |
|
|
30
AQR Capital Management
Greenwich,
Connecticut
| – | -$33.2K | -22,000 | Closed |
|
31
Bank of America
Charlotte,
North Carolina
| – | -$395 | -261 | Closed |
|
MIRA Hedge Fund Activity: Q1 2026 in Review
26 of the 8,127 institutional investors tracked by Wall St. Rank reported a position in MIRA Pharmaceuticals (MIRA) for Q1 2026, worth a combined $2.3M — down 31% from $3.35M a quarter earlier.
Buyers outnumbered sellers: 7 funds opened new MIRA positions and 5 closed out — a net gain of 2 holders — while 6 added to existing stakes and 1 trimmed.
The largest buyer was Susquehanna International Group, opening a new position worth an estimated $31.5K. The largest seller was Mirae Asset Global ETFs Holdings, exiting entirely with an estimated $472K sold.
- 26 institutional investors held MIRA Pharmaceuticals (MIRA) as of Q1 2026, up from 25 in Q4 2025.
- Funds reported $2.3M of MIRA Pharmaceuticals stock for Q1 2026, down 31% quarter-over-quarter.
- 7 funds opened new MIRA Pharmaceuticals positions in Q1 2026 and 5 closed out, a net change of +2 holders.
- The largest MIRA Pharmaceuticals buyer in Q1 2026 was Susquehanna International Group, an estimated $31.5K added.
- The largest MIRA Pharmaceuticals seller in Q1 2026 was Mirae Asset Global ETFs Holdings, an estimated $472K sold.
Based on aggregated 13F filings for Q1 2026.